The CLARION study: first report on safety findings in patients newly initiating treatment with cladribine tablets or fingolimod for multiple sclerosis
Article in Current Medical Research and Opinion (September 2023)
The most recent citing publications are shown below. View all 16 publications that cite this research output on Dimensions.
Article in Current Medical Research and Opinion (September 2023)
Article in International Immunopharmacology (May 2023)
Preprint in medRxiv (February 2023)